3//SEC Filing
Antibody Investments LLC 3
Accession 0001123292-18-000920
CIK 0001205922other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:32 PM ET
Size
7.4 KB
Accession
0001123292-18-000920
Insider Transaction Report
Form 3
VACCINEX, INC.VCNX
Antibody Investments LLC
10% Owner
Holdings
Series C Convertible Preferred Stock
→ Common Stock (1,346,139 underlying)Series D Convertible Preferred Stock
→ Common Stock (549,444 underlying)
Footnotes (2)
- [F1]The reported securities will convert into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The reported securities will convert into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001749340
Filing Metadata
- Form type
- 3
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:32 PM ET
- Size
- 7.4 KB